| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |